Illinois Tech Journal
SEE OTHER BRANDS

Your science and technology news reporter from Illinois

Illinois Tech Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Illinois Tech Journal.

Press releases published on June 10, 2025

Pulse Technology celebrates 70th anniversary

Pulse Technology celebrates 70th anniversary

Local, state and industry leaders join in June 4 celebration at Schaumburg, IL headquarters to congratulate second-generation, family technology business SCHAUMBURG, IL, UNITED STATES, June 10, 2025 /⁨EINPresswire.com⁩/ -- Much has changed since Pulse …

J. Blanton Plumbing teams up with Blick Art Materials for an in-store $100 gift card contest

J. Blanton Plumbing teams up with Blick Art Materials for an in-store $100 gift card contest

Chicago’s trusted plumbing company partners with Blick Art Materials for a $100 gift card giveaway and instant access to plumbing services. EVANSTON, IL, UNITED STATES, June 10, 2025 /⁨EINPresswire.com⁩/ -- J. Blanton Plumbing, a leading provider of …

TraknProtect Unveils Enterprise Safety Radio: A Game-Changer in Secure, Real-Time Communication

TraknProtect Unveils Enterprise Safety Radio: A Game-Changer in Secure, Real-Time Communication

TraknProtect is shaking up workplace communication with the launch of the Enterprise Safety Radio CHICAGO, IL, UNITED STATES, June 10, 2025 /⁨EINPresswire.com⁩/ -- TraknProtect is shaking up workplace communication with the launch of the Enterprise Safety …

Inprentus Diffraction Gratings Continue to Grow a Global Presence

Inprentus Diffraction Gratings Continue to Grow a Global Presence

Inprentus continues to serve critical global customers on 5 continents. CHAMPAIGN, IL, UNITED STATES, June 10, 2025 /⁨EINPresswire.com⁩/ -- Inprentus was founded in 2012 by University of Illinois Physics Professor Peter Abbamonte to commercialize a novel …

Symple Lending Releases Comprehensive Guide to Personal Loan Eligibility and Approval Tips

Symple Lending Releases Comprehensive Guide to Personal Loan Eligibility and Approval Tips

CHICAGO, IL, UNITED STATES, June 10, 2025 /⁨EINPresswire.com⁩/ -- Symple Lending, a trusted leader in personal finance solutions, has just published a new resource to help consumers navigate the often-confusing world of personal loan qualifications. The …

OrisDX Raises $4M Seed to Launch First-of-Its-Kind Saliva-Based Multiomic Platform, Targeting Oral Cancer

OrisDX Raises $4M Seed to Launch First-of-Its-Kind Saliva-Based Multiomic Platform, Targeting Oral Cancer

Pioneering saliva-based multiomic platform from Chicago secures $4M Seed from leading East and West coast investors to transform early oral cancer detection CHICAGO, IL, UNITED STATES, June 10, 2025 /⁨EINPresswire.com⁩/ -- OrisDX, a precision diagnostics …

Residential Real Estate Council's Virtual Summit Tackles AI in Real Estate

Residential Real Estate Council's Virtual Summit Tackles AI in Real Estate

RRC AI Unplugged: From Hype to Hands-On With Real Estate Pros June 18, 2025 | 1:00 - 4:00 p.m. CT | Fully Virtual CHICAGO, IL, UNITED STATES, June 10, 2025 /⁨EINPresswire.com⁩/ -- The Residential Real Estate Council (RRC) invites real estate …

Quest PharmaTech Announces Opposition to OQPBIOM's Acquisition of AdBioTech

Quest PharmaTech Announces Opposition to OQPBIOM's Acquisition of AdBioTech

EDMONTON, Alberta, June 10, 2025 (GLOBE NEWSWIRE) -- Quest PharmaTech Inc. (TSX-V: QPT) (“Quest” or the “Company”), a Canadian based pharmaceutical company developing products to improve the quality of life through investee companies and proprietary …

argenx Presents New Efgartigimod Data at EULAR 2025 Highlighting Positive Phase 2 Proof-of-Concept Results in Myositis and Sjogren’s Disease

argenx Presents New Efgartigimod Data at EULAR 2025 Highlighting Positive Phase 2 Proof-of-Concept Results in Myositis and Sjogren’s Disease

ALKIVIA data demonstrate significant improvement in muscle strength and physical function in myositis patients treated with efgartigimod RHO data show efgartigimod achieved sustained reduction in autoantibodies and improved functional outcomes in patients …

Philochem AG Announces the Licensing of Worldwide Rights to OncoACP3, a novel Radiopharmaceutical Therapeutic and Diagnostic Agent targeting Prostate Cancer, to RayzeBio, a Bristol-Myers Squibb Company, for a potential value of up to $1.35bn plus…

Philochem AG Announces the Licensing of Worldwide Rights to OncoACP3, a novel Radiopharmaceutical Therapeutic and Diagnostic Agent targeting Prostate Cancer, to RayzeBio, a Bristol-Myers Squibb Company, for a potential value of up to $1.35bn plus…

Consideration composed of a $350m up-front payment and up to $1.0bn in development, regulatory and commercial milestones, along with mid-single to low double-digit royalties on Global Net Sales OTELFINGEN, Switzerland, June 10, 2025 (GLOBE NEWSWIRE) -- …

BioAegis Therapeutics Announces US Navy Contract to Support Phase 2 Study of Recombinant Human Gelsolin, for Inflammasome-Driven Decompression Sickness (DCS)

BioAegis Therapeutics Announces US Navy Contract to Support Phase 2 Study of Recombinant Human Gelsolin, for Inflammasome-Driven Decompression Sickness (DCS)

NORTH BRUNSWICK, N.J., June 10, 2025 (GLOBE NEWSWIRE) -- BioAegis Therapeutics, a pioneering biotech company at the forefront of innovative therapies for acute and chronic inflammatory diseases, announces that it will conduct a Phase 2 study of rhu-pGSN …

Vaxart to Host Conference Call on June 11 at 8:30 AM ET to Discuss Topline Results from Its Phase I Norovirus Trial

Vaxart to Host Conference Call on June 11 at 8:30 AM ET to Discuss Topline Results from Its Phase I Norovirus Trial

SOUTH SAN FRANCISCO, Calif., June 10, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (NASDAQ: VXRT), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its proprietary delivery platform, today announced it will …

Xilio Therapeutics Appoints Akintunde Bello, Ph.D., to its Board of Directors

Xilio Therapeutics Appoints Akintunde Bello, Ph.D., to its Board of Directors

WALTHAM, Mass., June 10, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced the …

Micropolis Holding Company Filed Annual Report on Form 20-F for the Year Ended December 31, 2024

Micropolis Holding Company Filed Annual Report on Form 20-F for the Year Ended December 31, 2024

DUBAI, United Arab Emirates, June 10, 2025 (GLOBE NEWSWIRE) -- Micropolis Holding Company (“Micropolis” or the “Company”) (NYSE American: MCRP), a pioneer in unmanned ground vehicles and AI-driven security solutions, announced today that it has filed its …

CEA Industries to Participate at the Sidoti Conference on June 12, 2025

CEA Industries to Participate at the Sidoti Conference on June 12, 2025

Louisville, Colorado, June 10, 2025 (GLOBE NEWSWIRE) -- CEA Industries Inc. (NASDAQ: CEAD, CEADW) (“CEA Industries” or the “Company”), today announced its participation at the upcoming Sidoti Conference being held virtually June 11-12, 2025. CEA Industries …

Crinetics Pharmaceuticals Announces June 2025 Inducement Grants Under  Nasdaq Listing Rule 5635(c)(4)

Crinetics Pharmaceuticals Announces June 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, June 10, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on June 10, 2025, the Compensation Committee of the Board of Directors granted non-qualified stock option awards to purchase an aggregate of 74 …

Vimeo Elects Adam Cahan, Lydia Jett, and Kirsten Kliphouse to Board of Directors

Vimeo Elects Adam Cahan, Lydia Jett, and Kirsten Kliphouse to Board of Directors

NEW YORK, June 10, 2025 (GLOBE NEWSWIRE) -- Vimeo, Inc. (NASDAQ: VMEO), one of the largest and most trusted private video networks in the world, today announced the election of Adam Cahan, Lydia Jett, and Kirsten Kliphouse to its Board of Directors. The …

Voting Rights and Shares Capital of the Company

Voting Rights and Shares Capital of the Company

In accordance with articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (Autorité des Marchés Financiers) PARIS, June 10, 2025 (GLOBE NEWSWIRE) -- Market: Euronext Paris / Nasdaq …

Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social

Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social

Conformément aux articles L.233-8 II du Code de commerce et 223-16 du Règlement Général de l’Autorité des Marchés Financiers PARIS, 10 juin 2025 (GLOBE NEWSWIRE) -- Place de cotation : Euronext Paris / Nasdaq Euronext Compartiment : B Code ISIN : …

Celularity Announces Chief Financial Officer Transition

Celularity Announces Chief Financial Officer Transition

FLORHAM PARK, N.J., June 10, 2025 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity” or the “Company”), a regenerative and cellular medicine company, today announced that it terminated the employment of its Chief Financial Officer (“CFO”), …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions